The accompanying notes form an integral part of these Consolidated Financial Statements.
1 O n 27 February 2017, the UK Governments Lord Chancellor announced a reduction in the personal injury discount rate the Ogden rate from 2.5% to minus 0.75%.
The Group has therefore adopted the discount rate of minus 0.75% to estimate personal injury claims liabilities at 31 December 2016.
This was considered to warrant separate disclosure due to the significance of the impact, which is further disclosed within Note 11.
2 N on-trading items are defined as expenses or earnings that are not representative of the underlying activities of the Group and include reorganisation, refinancing and transaction costs, preference share dividends and the impact of accounting for business combinations, as described in Note 12.
3 A djusted operating profit represents profit before taxation expense, finance costs, amortisation and depreciation and non-trading costs.
This is a non-IFRS measure used by management to measure the underlying trading of the business and is provided for information.
